Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15207068rdf:typepubmed:Citationlld:pubmed
pubmed-article:15207068lifeskim:mentionsumls-concept:C0680399lld:lifeskim
pubmed-article:15207068lifeskim:mentionsumls-concept:C0008300lld:lifeskim
pubmed-article:15207068lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:15207068lifeskim:mentionsumls-concept:C0949285lld:lifeskim
pubmed-article:15207068pubmed:issue6lld:pubmed
pubmed-article:15207068pubmed:dateCreated2004-6-21lld:pubmed
pubmed-article:15207068pubmed:abstractTextTwo types of cohort studies examining patients infected with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) were contrasted, using different reference groups. Cases were compared to uninfected patients and patients infected with the corresponding, susceptible organism. VRE and MRSA were associated with adverse outcomes. The effect was greater when uninfected control patients were used.lld:pubmed
pubmed-article:15207068pubmed:languageenglld:pubmed
pubmed-article:15207068pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15207068pubmed:citationSubsetIMlld:pubmed
pubmed-article:15207068pubmed:statusMEDLINElld:pubmed
pubmed-article:15207068pubmed:monthJunlld:pubmed
pubmed-article:15207068pubmed:issn1080-6040lld:pubmed
pubmed-article:15207068pubmed:authorpubmed-author:KayeKeith SKSlld:pubmed
pubmed-article:15207068pubmed:authorpubmed-author:CarmeliYehuda...lld:pubmed
pubmed-article:15207068pubmed:authorpubmed-author:MozaffariEssy...lld:pubmed
pubmed-article:15207068pubmed:authorpubmed-author:EngemannJohn...lld:pubmed
pubmed-article:15207068pubmed:issnTypePrintlld:pubmed
pubmed-article:15207068pubmed:volume10lld:pubmed
pubmed-article:15207068pubmed:ownerNLMlld:pubmed
pubmed-article:15207068pubmed:authorsCompleteYlld:pubmed
pubmed-article:15207068pubmed:pagination1125-8lld:pubmed
pubmed-article:15207068pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:meshHeadingpubmed-meshheading:15207068...lld:pubmed
pubmed-article:15207068pubmed:year2004lld:pubmed
pubmed-article:15207068pubmed:articleTitleReference group choice and antibiotic resistance outcomes.lld:pubmed
pubmed-article:15207068pubmed:affiliationDuke University Medical Center, Durham, North Carolina 27710, USA. kaye0001@mc.duke.edulld:pubmed
pubmed-article:15207068pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15207068pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15207068lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15207068lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15207068lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15207068lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15207068lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15207068lld:pubmed